1,442 results
·
51ms
·
Sources: EU EUDAMED, US FDA
System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
FDA Pre-Market Approval
FDA Class 3
·Cologuard
Sensor, Glucose, Implanted, Non-Adjunctive Use
FDA Pre-Market Approval
FDA Class 3
·Eversense Continuous Glucose Monitoring System
System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
FDA Pre-Market Approval
FDA Class 3
·Epi proColon
System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
FDA Pre-Market Approval
FDA Class 3
·COLOGUARD
System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
FDA Pre-Market Approval
FDA Class 3
·COLOGUARD
System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
FDA Pre-Market Approval
FDA Class 3
·Multi-Target Stool DNA (mtsDNA) Test, Cologuard Plus
System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
FDA Pre-Market Approval
FDA Class 3
·COLOGUARD
Sensor, Glucose, Implanted, Non-Adjunctive Use
FDA Pre-Market Approval
FDA Class 3
·Eversense® E3 Continuous Glucose Monitoring System
System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
FDA Pre-Market Approval
FDA Class 3
·Shield
System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
FDA Pre-Market Approval
FDA Class 3
·Shield
System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
FDA Pre-Market Approval
FDA Class 3
·Cologuard
System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
FDA Pre-Market Approval
FDA Class 3
·COLOGUARD
System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
FDA Pre-Market Approval
FDA Class 3
·Shield
System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
FDA Pre-Market Approval
FDA Class 3
·Shield
System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
FDA Pre-Market Approval
FDA Class 3
·Epi proColon
Sensor, Glucose, Implanted, Non-Adjunctive Use
FDA Pre-Market Approval
FDA Class 3
·Eversense E3 Continuous Glucose Monitoring System
Sensor, Glucose, Implanted, Non-Adjunctive Use
FDA Pre-Market Approval
FDA Class 3
·Eversense E3 Continuous Glucose Monitoring System (CGM System) - Entire System, Eversense E3 Sensor, Eversense E3 Insert
System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
FDA Pre-Market Approval
FDA Class 3
·Cologuard
System, Colorectal Neoplasia, Dna Methylation And Hemoglobin Detection
FDA Pre-Market Approval
FDA Class 3
·Cologuard
Sensor, Glucose, Implanted, Non-Adjunctive Use
FDA Pre-Market Approval
FDA Class 3
·Eversense® E3 Continuous Glucose Monitoring (CGM) System